Evercore ISI Says Gilead Sciences (GILD) Tenofovir Risk 'waning'
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $137.80 -0.25%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Evercore ISI analyst Umer Raffat reiterated an Outperform rating and {REMOVEPT} price target on Gilead Sciences (NASDAQ: GILD).
The analyst comments "tenofovir litigation is waning"
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $83.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- McGraw Hill (MH) PT Raised to $15 at UBS
- Wolfe Research Downgrades T-Mobile (TMUS) to Peerperform
Create E-mail Alert Related Categories
Analyst Comments, Hot CommentsRelated Entities
Umer RaffatSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
